Nanorx founder Dr Raghavan to present Metadichol’s tuberculosis treatment effectiveness at Infectious Diseases conference
- by Team ABLE - 13 May, 2019
Metadichol, a Nano emulsion of food-based ingredient, created by Nanorx Inc., has shown results, that could lead to its in prevention and treatment of tuberculosis (TB). Recent in-vitro studies, conducted in the US and India, show that the Metadichol inhibits TB strains, H37Rv, MDR (multiple drug resistant) and XDR (extensively drug-resistant).The founder of Nanorx Inc, Dr P R Raghavan, will present the research results at an upcoming International conference on Infectious Diseases.
“The recent research on Metadichol's effect on tuberculosis is promising,” said Dr P.R. Raghavan, Chairman of Nanorx Inc. “Metadichol has been known to enhance the innate immune response, but this work shows it also has an inhibitory effect on the various forms of TB. Because Metadichol is made with natural ingredients and has no toxic effects, it can be safely tested humans for its prevention and treatment of many infectious diseases.”
The press statement indicates that plans are underway to test it in humans to evaluate its effectiveness as an immune booster in TB prevention and treatment.Tuberculosis (TB) continues to pose a significant global infectious disease threat. Worldwide, 9 million new cases and 1.6 million deaths were reported in 2017. Currently, drug resistant strains, MDR TB. and XDR TB are the emerging threats to the success of the anti-TB programs that are in place globally.
Bacteria and viruses and other microbes have evolved and survived by binding to VDR (Vit D Receptor) and curtailing its functions. which is responsible for the maintenance of innate immunity. This allows them to infect humans and multiply using the body’s machinery. It was explained in the release that Metadichol competitively displaces the bacteria that are attached to the VDRs and allows normal functioning of innate immunity. TB strikes when one’s immune system is compromised and strengthening the immune system through use of Metadichol® is thus an attractive approach.
It was also mentioned that Metadichol is produced by a patented nanotechnology process, that creates an absorbable nano-emulsion of long-chain alcohols, from policosanol, found in a variety of foods like peanuts, sugar cane, rice, and wheat.
Metadichol is a nano emulsion made out of a food-based ingredient, created by Nanorx Inc, which has been found to prevent and treat tuberculosis.